GlaxoSmithKline News and Research

RSS

Elephantiasis and river blindness: MSU researcher receives $2M for reformulating flubendazole

In an effort to eliminate the tropical diseases elephantiasis and river blindness, a Michigan State University researcher has been awarded $2 million to reformulate an existing drug that could stop the debilitating diseases in their tracks.

5 Feb 2010

Early stage trial finds malaria vaccine effectively protected young children, study says

An experimental vaccine was found to effectively protect young children from malaria in Mali, Reuters reports. According to the news service, "The vaccine, which uses an immune system booster called an adjuvant from British drugmaker GlaxoSmithKline, targets the malaria parasite as it is actively infecting red blood cells and causing fever and illness" (Steenhuysen, 2/3).

5 Feb 2010

New vaccine to prevent malaria infection shown promise to protect young children

A new vaccine to prevent the deadly malaria infection has shown promise to protect the most vulnerable patients - young children - against the disease, according to an international team of researchers led by the University of Maryland School of Medicine's Center for Vaccine Development (CVD) and the Malaria Research and Training Center at the University of Bamako in Mali, West Africa.

4 Feb 2010

Drug company CEOs under pressure

Dow Jones Newswires/The Wall Street Journal on Severin Schwan, chief executive of Swiss pharmaceutical company Roche Holding AG: "'It is difficult to gauge the impact of the planned U.S. healthcare reform on the pharmaceutical industry,' Schwan told reporters at a media conference to detail 2009 earnings. 'On the one hand, more U.S. citizens will be getting access to healthcare, which is positive. At the same time, pressure on drug prices will certainly increase,' he added." The wire service adds that he also said "decisions on generic biosimilars will be key" (Greil, 2/3).

3 Feb 2010

Hundred millions for biotech-licence

Apeiron Biologics AG (Apeiron) today announced the signing of an agreement granting GlaxoSmithKline (GSK) exclusive rights to APN01 (recombinant human Angiotensin Converting Enzyme 2, rhACE2), an enzyme biotherapeutic currently in Phase 1 development for the treatment of the Acute Respiratory Distress Syndrome (ARDS).

3 Feb 2010

NanoBio awarded sixth U.S. patent covering its novel nanoemulsion technology

NanoBio Corporation announced today that a sixth U.S. patent covering its novel nanoemulsion technology has been awarded. The patent encompasses composition of matter claims for the company’s lead anti-infective and vaccine product candidates.

3 Feb 2010

Tips to prevent heartburn

With the Big Game approaching, many football fans across the country are preparing for viewing parties, and the non-stop eating that comes with them. But favorite football foods like pizza, wings and nachos can trigger heartburn, which can end the evening long before the last touchdown.

3 Feb 2010

American PhRMA companies commit $25M in medicines, medical supplies and cash for Haiti relief efforts

As the need for health care assistance mounts after the recent catastrophic earthquake in Haiti, America's pharmaceutical research and biotechnology companies continue to provide help. So far, more than $25 million in medicines, medical supplies and cash have been committed to relief efforts – and that amount is still growing. The total does not include the contributions of PhRMA member company employees and the many companies committed to matching the pledges of their workers.

30 Jan 2010

Canada to donate 5m doses of H1N1 vaccine to WHO; agency has received commitment of 200m vaccines

The Canadian government on Thursday announced the country would donate five million doses of H1N1 vaccines to the WHO from the country's current surplus, the Canadian Press reports (Branswell, 1/28).

30 Jan 2010

FDA approves new drug combination for hormone positive and HER2-positive advanced breast cancer

The U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.

30 Jan 2010

GlaxoSmithKline's Lamictal XR Extended-Release Tablets receive FDA approval

laxoSmithKline announced today that the U.S. Food and Drug Administration has approved Lamictal®XR™ (lamotrigine) Extended-Release Tablets as once-a-day, add-on therapy for epilepsy in patients ages 13 years and older with primary generalized tonic-clonic seizures.

29 Jan 2010

FDA grants accelerated approval for GlaxoSmithKline's TYKERB

GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for a new combination regimen using TYKERB® (lapatinib) as a first-line, all-oral treatment for women with metastatic breast cancer.

29 Jan 2010

Rotavirus vaccine could save millions of children in developing countries, studies find

Efforts to vaccinate "infants against rotavirus could save the lives of millions of children in developing nations who would otherwise die from the diarrhea-causing disease, two new studies show," HealthDay/BusinsessWeek reports.

28 Jan 2010

Studies in Mexico and Africa demonstrate the effectiveness of rotavirus vaccine

For the first time ever, studies in Mexico and Africa, published today in the New England Journal of Medicine, demonstrate a reduction in diarrheal disease deaths following rotavirus vaccine introduction in Mexico and vaccine efficacy among impoverished populations in Malawi and South Africa.

28 Jan 2010

New technique could reduce animal use in gene study

A new method of priming early embryos to form embryonic stem (ES) cells has allowed ES cells to be derived from mice used in diabetes research for the first time.

28 Jan 2010

Alli boosts weight loss and reduces excess visceral fat

New studies show that overweight and obese people using alli® (orlistat 60 mg) with a reduced calorie, lower-fat diet can significantly reduce weight, visceral fat, and waist circumference and therefore may reduce their risk of type 2 diabetes, hypertension, heart disease and stroke.

28 Jan 2010

Amarin reviews 2009 accomplishments; outlines strategy for 2010 and beyond

Amarin Corporation plc, a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, today issued a special letter to its shareholders.

28 Jan 2010

African vaccine maker plans to increase production capacity sevenfold by 2013

Biovac Institute, a South African vaccine maker, said Monday that it is working with other major pharmaceutical firms to increase its annual capacity sevenfold to 35 million doses by 2013, Reuters reports.

28 Jan 2010

Researchers renew hope that effective vaccine could be developed against Salmonella infection

Research from Malawi, Birmingham and Liverpool has renewed hope that an effective vaccine could be developed against nontyphoidal strains of Salmonella. The work, funded by the Wellcome Trust and GlaxoSmithKline, suggests that the body's immune system could be primed to tackle even the most resilient of strains.

27 Jan 2010

WHO rejects accusations it mishandled H1N1, updates worldwide stats

WHO spokesperson Gregory Hartl on Monday rejected accusations that the organization miscategorized H1N1 (swine flu) as a pandemic, calling such accusations "irresponsible," the Associated Press/Washington Post reports. "WHO also dismissed claims it colluded with drug companies to bring economic benefit to the industry by playing up the danger of the new H1N1 [swine flu] influenza strain," the news service writes.

27 Jan 2010

GlaxoSmithKline News and Research

Elephantiasis and river blindness: MSU researcher receives $2M for reformulating flubendazole

Early stage trial finds malaria vaccine effectively protected young children, study says

New vaccine to prevent malaria infection shown promise to protect young children

Drug company CEOs under pressure

Hundred millions for biotech-licence

NanoBio awarded sixth U.S. patent covering its novel nanoemulsion technology

Tips to prevent heartburn

American PhRMA companies commit $25M in medicines, medical supplies and cash for Haiti relief efforts

Canada to donate 5m doses of H1N1 vaccine to WHO; agency has received commitment of 200m vaccines

FDA approves new drug combination for hormone positive and HER2-positive advanced breast cancer

GlaxoSmithKline's Lamictal XR Extended-Release Tablets receive FDA approval

FDA grants accelerated approval for GlaxoSmithKline's TYKERB

Rotavirus vaccine could save millions of children in developing countries, studies find

Studies in Mexico and Africa demonstrate the effectiveness of rotavirus vaccine

New technique could reduce animal use in gene study

Alli boosts weight loss and reduces excess visceral fat

Amarin reviews 2009 accomplishments; outlines strategy for 2010 and beyond

African vaccine maker plans to increase production capacity sevenfold by 2013

Researchers renew hope that effective vaccine could be developed against Salmonella infection

WHO rejects accusations it mishandled H1N1, updates worldwide stats

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News